Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population

Jia Wei*, Nicole Stoesser, Philippa C. Matthews, Tarnjit Khera, Owen Gethings, Ian Diamond, Ruth Studley, Nick Taylor, Tim E.A. Peto, A. Sarah Walker, Koen B. Pouwels, David W. Eyre, Emma Rourke, Tina Thomas, Dawid Pienaar, Joy Preece, Sarah Crofts, Lina Lloyd, Michelle Bowen, Daniel AyoubkhaniRussell Black, Antonio Felton, Megan Crees, Joel Jones, Esther Sutherland, Derrick W. Crook, Emma Pritchard, Karina Doris Vihta, Alison Howarth, Brian D. Marsden, Kevin K. Chau, Lucas Martins Ferreira, Wanwisa Dejnirattisai, Juthathip Mongkolsapaya, Sarah Hoosdally, Richard Cornall, David I. Stuart, Gavin Screaton, Katrina Lythgoe, David Bonsall, Tanya Golubchik, Helen Fryer, John N. Newton, John I. Bell, Stuart Cox, Kevin Paddon, Tim James, Thomas House, Julie Robotham, Paul Birrell, Helena Jordan, Tim Sheppard, Graham Athey, Dan Moody, Leigh Curry, Pamela Brereton, Ian Jarvis, Anna Godsmark, George Morris, Bobby Mallick, Phil Eeles, Jodie Hay, Harper VanSteenhouse, Jessica Lee, Sean White, Tim Evans, Lisa Bloemberg, Katie Allison, Anouska Pandya, Sophie Davis, David I. Conway, Margaret MacLeod, Chris Cunningham

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science